Regeneron Pharmaceuticals Inc (REGN)
701.85
-6.40
(-0.90%)
USD |
NASDAQ |
Dec 20, 16:00
707.00
+5.15
(+0.73%)
After-Hours: 20:00
Regeneron Pharmaceuticals Profit Margin (Quarterly): 36.03% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 33.28% |
| Eli Lilly and Co | 8.48% |
| Pfizer Inc | 25.22% |
| Biogen Inc | 15.76% |
| AbbVie Inc | 10.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.19% |
| Return on Assets | 13.44% |
| Return on Invested Capital | 16.02% |
| Gross Profit Margin (Quarterly) | 86.80% |
| Operating Margin (Quarterly) | 33.21% |
| Return on Net Operating Assets | 33.97% |